INTRODUCTION {#SEC1}
============

Meiosis is a fundamental event of sexual reproduction. Failures in meiosis are the leading cause of infertility and birth defects ([@B1]). During meiosis, progenitor cells undergo a single round of DNA replication, followed by two successive rounds of cell division to generate haploid gametes. DNA crossover recombination (CO) is a crucial event of meiosis that not only promotes the exchange of genetic information between parents but also establishes the physical connections between homologous chromosomes (homologs), required for proper chromosome segregation ([@B4]).

Meiotic recombination is initiated by SPO11 complex-mediated programmed DNA double-strand breaks (DSBs) ([@B5]). After SPO11 complex and its binding oligos are removed by MRE11, the DSB ends are further resected primarily by the MRE11-RAD50-NBS1 exonuclease complex to generate single strand 3′ overhangs ([@B9],[@B12]). This single stranded DNA (ssDNA) is protected by replication protein A (RPA), and then RecA-like proteins DMC1 and RAD51 are recruited to promote the formation of displacement loops (D-loops) ([@B13],[@B14]). A small fraction of D-loops is selected to generate single-end invasions (SEIs). However, the majority of D-loops develop into non-crossovers (NCOs) ([@B12],[@B15]). SEIs are CO specific recombination intermediates, which will develop into double-Holliday junctions (dHJs) ([@B15]). Normally, dHJs are specifically resolved to COs by the MLH1-MLH3 complex ([@B12],[@B15]). The process of CO recombination is tightly regulated by a set of factors, especially the well-known 'ZMM' proteins, which include Zip1-4, Msh4-5, Mer3 and Spo16 in budding yeast ([@B12],[@B15]). Absence of or aberrantly located COs tend to result in chromosome mis-segregation and thus aneuploidy ([@B1],[@B2],[@B12],[@B15],[@B18]).

Recombinase DMC1 and its accessory factor RAD51 mediate the central step of meiotic DSB repair by catalyzing the nucleoprotein filament to search and invade its homolog partner to form D-loops ([@B13],[@B19]). The mechanism(s) regulating DMC1/RAD51-ssDNA filaments remain(s) to be elucidated. Studies have identified several factors involved in this process, including HOP2-MND1, HSF2BP, TEX15, ATR, BRCA1, BRCA2, MEIOB and SWS1-SWSAP1 ([@B20]). However, how these factors collaborate and recruit DMC1/RAD51 to recombination sites is unknown. One study has shown that without HSF2BP, both DMC1/RAD51 and BRCA2 foci are almost abolished. The authors proposed that HSF2BP interacts with BRCA2, and thus recruits BRCA2-DMC1/RAD51 to DSB sites ([@B28],[@B30]). However, *Brca2* mutants show meiosis failures in both males and females. Paradoxically, *Hsf2bp* mutants show severe meiosis defects only in males but not in females ([@B22],[@B28],[@B30]). Therefore, how HSF2BP regulates DMC1/RAD51 foci still remains unclear.

During meiosis, one long-lasting question is how RAD51/DMC1-ssDNA nucleoprotein filaments move recombination factors forward to search and invade its homologous DNA. A recombination 'bridge' model has been proposed and further elaborated recently ([@B31],[@B32]). In this model, cytologically visualized bridge-like structures have been thought to mediate the movement of meiotic recombination factors ([@B31],[@B32]). These bridge-like structures are built between the two axes of homologs in the zygotene stage, consisting of DNA, axis proteins and recombination-related proteins, e.g. Spo76/Pds5, Mer3-Msh4 and the Zip2-4 complex in the fungus *Sordaria* ([@B31]). Recombination bridges are found in diverse species from fungi and plants to mammals ([@B31]). Currently, however, only a few proteins have been found to be involved in recombination bridges. Therefore, identification of new components of recombination bridges will help us to further understand their formation and clarify the mechanisms of meiotic DSB repair.

In this study, we identified a previously uncharacterized protein, as a novel meiotic recombination factor and a component of recombination bridges, which we termed **meio**sis-specific *4930432****K21****RIK* (*Meiok21*). During meiosis, MEIOK21 is recruited to chromosomes and localizes on recombination sites in a DSB-dependent manner. MEIOK21 first appears on the chromosome axis at leptotene. Along with the progression of meiotic recombination, MEIOK21 is released from the axis to form bridge-like structures linking homolog axes before they are synapsed. Finally, MEIOK21 foci are located between synapsed homolog axes and on the synaptonemal complex (SC). Knockout of *Meiok21* results in male mice infertility. Additional experiments showed that greatly decreased DMC1/RAD51 focus number on chromosomes disrupts DSB repair, synapsis and crossover formation in *Meiok21^−/−^* mice. Furthermore, MEIOK21 physically interacts with HSF2BP, and in *Meiok21^−/−^* spermatocytes, the loading of HSF2BP to recombination sites is also sharply reduced. Therefore, our results suggest that through interaction with HSF2BP, MEIOK21 regulates DMC1/RAD51-ssDNA nucleoprotein filaments to promote meiotic homologous recombination.

MATERIALS AND METHODS {#SEC2}
=====================

Animals {#SEC2-1}
-------

*Meiok21* knockout mice were constructed using the CRISPR/Cas9 system. The mouse *4930432K21RIK* gene (GenBank: [NM_029045.2](NM_029045.2); Ensembl: ENSMUSG00000008129) is located on chromosome 8 and contains nine exons with the start codon in the second exon and the stop codon in the last exon. To construct the *Meiok21* knockout mice, exon 3 to exon 6 were deleted. All WT and knockout mice had a C57BL/6 background. The gene knockout founders were genotyped by PCR followed by DNA sequencing analysis. The homozygous mutant mice were generated by intercross of heterozygous mutants.

The *Spo11* knockout mice were kindly provided by Prof. Hongbin Liu from Shandong University, and *Dmc1* knockout mice were kindly provided by Prof. Minghan Tong from the Shanghai Institute of Biochemistry and Cell Biology, CAS.

The use of mice was approved by the Animal Ethics Committee of the School of Medicine, Shandong University. All animal care protocols and experiments in this study were reviewed and approved by the Animal Use Committee of the School of Medicine, Shandong University.

Genotyping {#SEC2-2}
----------

Mutant mice genotyping was performed by PCR amplification of genomic DNA extracted from mouse tail tips ([@B33]). The PCR primers for the *Meiok21* mutant allele were: (Forward) 5′-AAT CTT GGG AGC TGG AGT ATG CTC TG-3′ and (Reverse) 5′-CCT TCA GCC CCT CTA CTA CAC ACT ATG-3′, and the PCR product was 710 bp. PCR primers for the wild-type *Meiok21* allele were: (Forward) 5′- AGG GAG AGA TAG GAA GCC TGT CAG TC-3′ and (Reverse) 5′-CCT TCA GCC CCT CTA CTA CAC ACT ATG-3′, and the PCR product was 469 bp.

Plasmids and antibodies {#SEC2-3}
-----------------------

Full length *Meiok21* cDNA was cloned from mouse testis cDNA by PCR. The PCR product bearing *Meiok21* and pGBKT7 vector plasmid were digested with EcoRI and XhoI and ligated to produce *Meiok21*-pGBKT7, which was confirmed by sequencing. Full length or truncated *Meiok21* cDNA was subcloned from *Meiok21*-pGBKT7 plasmid by PCR. After digestion by EcoRI and XmaI, they were ligated with pCAG-GFP vector digested by the same restriction enzymes. Full length or truncated *Hsf2bp* cDNA was cloned from mouse testis cDNA by PCR and inserted into PRK vector after digestion by SalI and NotI.

Rabbit and guinea pig anti-MEIOK21 polyclonal antibody was prepared against amino acids 1--230 of mouse MEIOK21 protein by Dai-an Biological Technology Incorporation (Wuhan, China) as previously described ([@B34]). Primary antibodies used for immunostaining were as follows: rabbit anti-MEIOK21 (1:200), guinea pig anti-MEIOK21 (1:100, coimmunostaining with RPA2, RAD51, DMC1 or HSF2BP), mouse anti-SYCP3 (1:800; Abcam \#ab97672), rabbit anti-SYCP1 (1:800; Abcam \#ab15090), rabbit anti-RPA2 (1:500; Abcam \#ab76420), rabbit anti-RAD51 (1:100; Thermo Fisher Scientific \#PA5-27195), rabbit anti-DMC1 (1:100; Proteintech \#13714-1-AP50), mouse anti-phospho-Histone H2A.X (Ser139) (clone JBW301, 1:300; Millipore \#05-636), mouse anti-MLH1 (1:100; BD Biosciences \#550838), rabbit anti-HSF2BP (1:200; Abcam \#ab126252), rabbit anti-BRCA2 (1:200; Abcam \#ab123491). Secondary antibodies were: Alexa Fluor 594-conjugated goat anti-mouse (1:500; Proteintech, \#CL594-66467), Alexa Fluor 405-conjugated donkey anti-mouse (1:500; Abcam, \#175658), Alexa Fluor 488-conjugated goat anti-rabbit (1:500; Abcam, \#ab150077), Alexa Fluor 594-conjugated goat anti-rabbit (1:500; Abcam, \#150088), Alexa Fluor 488-conjugated goat anti-guinea pig (1:500; Abcam, \#150185).

Fertility test {#SEC2-4}
--------------

Fertility was tested in male mice of the indicated genotypes (8--12 weeks, *n* = 5). Each male mouse was caged with two wild-type C57BL/6 females (4--6 weeks), that were checked for vaginal plugs every morning. Once a vaginal plug was identified (day 1 postcoitus), the male was allowed to rest for 2 days, then another female was placed in the cage for another round of mating. The plugged female was separated and singly caged, and the pregnancy was recorded. If a female did not generate any pups by day 22 postcoitus, it was deemed as not pregnant and euthanized to confirm that result. The fertility test lasted for 2 months.

Yeast two hybrid assay {#SEC2-5}
----------------------

Yeast two-hybrid assay (Y2H) was performed as described previously ([@B35]). Mouse *Meiok21* cDNA was subcloned into pGADT7 vector as prey. Mouse *Rad51*, *Dmc1, Hsf2bp*, *Rpa1*, *Rpa2*, *Rpa3*, *Spata22* and *Meiob* cDNA were separately subcloned into pGBKT7 vector as bait. The bait and prey plasmids were co-transformed into Y2H gold strain and the interaction was tested on SD-Leu-Trp-His plates.

Immunoprecipitation assay {#SEC2-6}
-------------------------

Testes (∼200 mg) or 2 × 10^7^ transfected HEK-293T cells were treated with lysis buffer (50 mM Tris--HCl, pH 8.0, 120 mM NaCl, 20 mM NaF, 20 mM β-glycerophosphate, 1 mM EDTA, 6 mM EGTA, pH 8.0, 1% NP-40, 1 mM DTT) on ice for 30 min, then centrifuged at 12 000 × *g* for 10 min at 4°C. About 5% of the supernatant was used as input. Half of the remaining supernatant was incubated with ∼2 μg of the corresponding primary antibody and the other half was incubated with ∼2 μg IgG overnight. Then the antibodies were conjugated with protein A/G-magnification beads (MedChemExpress, HY-K0202) for 2 h. After washing, SDS loading buffer was added to the beads and the mixture was boiled at 95°C for 5 min. Samples were separated by SDS-PAGE and immunoblotted with indicated primary and secondary antibodies.

Histological and surface nuclear spread analyses {#SEC2-7}
------------------------------------------------

Mice testes and cauda epididymis were isolated immediately after euthanasia, fixed in Bouin\'s solution (Sigma, \#HT10132-1L) for 24 h, and then embedded in paraffin. Five-micron sections were prepared and mounted on glass slides. After deparaffinization, slides were stained with hematoxylin and eosin (HE) for histological analysis. TUNEL staining was performed with TUNEL kit (keyGEN BioTECH, \#KGA7072) following the manufacturer\'s instructions. PAS staining was performed with Periodic Acid Schiff (PAS) Stain Kit (Abcam, ab150680). Stages of seminiferous epithelium cycle and spermatid development were determined as previously described ([@B36]). For chromosome spread, testicular tubules were pretreated by hypotonic buffer (30 mM Tris, 50 mM sucrose, 17 mM trisodium citrate dihydrate, 5 mM EDTA, 0.5 mM DTT and 0.5 mM phenylmethylsulphonyl fluoride (PMSF), pH 8.2) for 30 min. Short fragments of testicular tubules were suspended in 0.1 M sucrose and dispersed to single cells, then spread to a thin cell layer on glass slides, and treated with 1% (w/v) paraformaldehyde solution containing 0.15% Triton X-100 ([@B37]).

Imaging {#SEC2-8}
-------

Immunostained slides were imaged by confocal microscopy (Andor Dragonfly spinning disc confocal microscope driven by Fusion Software). Histology results were analyzed using an epifluorescence microscope (BX52, Olympus). Super-resolution structured illumination microscopy (SIM) analysis was performed using Acquire SR software on a DeltaVision OMX SR super resolution imaging system (GE Healthcare) equipped with a 60×/1.42 oil objective, and the images were further computationally reconstructed and processed with softWoRx software (GE Healthcare) to generate super resolution optical series sections with two-fold extended resolution in *x*, *y* and *z* axes.

Reverse transcriptional PCR (RT-PCR) and qPCR (RT-qPCR) {#SEC2-9}
-------------------------------------------------------

Total RNA was isolated from different tissues of mice. To analyze the expression of *Meiok21* mRNAs, cDNA was synthesized using the PrimeScript RT reagent Kit with gDNA Eraser (Takara). qPCR was performed using UltraSYBR Mixture (CWBiotech) and specific forward and reverse primers; the input of cDNA for each sample was 200 ng. *Meiok21* primers: (Forward, on exon 3) 5′-GGG AGG AAC CAC TAC ACG A-3′ and (Reverse, on exon 6) 5′- GCT TTG AGG G CT CCC AGC TC-3′. β-Actin was amplified as a housekeeping gene with the primers (Forward) 5′-CAT CCG TAA AGA CCT CTA TGC CAA C-3′ and (Reverse) 5′-ATG GAG CCA CCG ATC CAC A-3′. All PCR reactions were performed with an initial denaturation at 95°C for 10 min followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 s, extension at 72°C for 30 s and a final extension at 72°C for 5 min. The *Meiok21* expression level was quantified by the ΔCT method and the PCR products were analyzed on a 2% agarose gel.

To confirm *Meiok21* knockout efficiency, RT-PCR was performed using the same primers used for RT-qPCR. To detect possible transcripts in *Meiok21* knockout, another RT-PCR was performed using the following primers outside of the knockout region. Forward (on 5′ UTR): 5′-CAG AGC AAC TTC CAT TAC TGC-3′ and Reverse (on 3′UTR): 5′-ACA AAC TCA ACG ACA ACT GC-3′. The RT-PCR reaction was performed with an initial denaturation at 95°C for 3 min followed by 35 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 s, extension at 72°C for 30 s and a final extension at 72°C for 5 min. The PCR products were analyzed on a 2% agarose gel and sequenced.

Statistical analysis {#SEC2-10}
--------------------

Statistical analyses were conducted using GraphPad PRISM version 5.01 (GraphPad Software, Inc. RRID:SCR_002798). The error bars show means ± SEM or means ± SD as indicated in figure legends. Sample sizes were described in figure legends. The statistical significance of the differences between two sets of data was measured by Student\'s *t*-test with an unpaired, two-tailed distribution. The levels of significance are indicated as follows: *P* \< 0.05 (\*), *P* \< 0.01 (\*\*) and *P* \< 0.001 (\*\*\*).

RESULTS {#SEC3}
=======

MEIOK21 specifically localizes on meiotic chromosomes {#SEC3-1}
-----------------------------------------------------

To understand the mechanisms of meiotic recombination, RNA sequencing of mouse germ cells was conducted to identify new factors involved in meiotic DSB repair and recombination ([@B33]). An uncharacterized gene *4930432K21RIK* was selected based on its preferential expression in germ cells during meiosis, which was also previously identified as being highly expressed in mouse testes ([@B38]). This gene is 44.57 kb, located on chromosome 8. It contains nine exons with start codon ATG in the second exon and stop codon TAA in the last exon, and the ORF is 1,800 bp, encoding 600 amino acids. By searching its sequence in public databases, including NCBI, Uniprot and Protein Data Bank, we found that 4930432K21RIK protein only exists in vertebrates and is rather conserved ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). It belongs to an unknown protein superfamily (cl25823), which contains a conserved structural domain with unknown function (DUF4671; <https://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=318011>). Its human ortholog is C19ORF57, which is also preferentially expressed in testes ([@B39]). To further study the expression patterns of *4930432K21RIK*, reverse transcription qPCR (RT-qPCR) was performed. We found that mRNA was highly expressed in mouse testes and fetal ovaries (Figure [1A](#F1){ref-type="fig"} and [Supplementary Figure S1BC](#sup1){ref-type="supplementary-material"}). According to its biological function described below, this gene was named *Meiok21* (**meio**sis-specific *4930432****K21****RIK*).

![Dynamic localization of MEIOK21 on meiotic chromosomes. (**A**) *Meiok21* is highly expressed in testes and fetal ovaries, revealed by RT-qPCR. (**B**) The dynamic localization of MEIOK21 to meiotic chromosomes in mouse spermatocytes. The meiotic stages of spermatocytes were determined by the SYCP3 staining (red) of the chromosome axis. MEIOK21 (green) are visualized on meiotic chromosomes from leptotene to late pachytene and are undetectable in diplotene. The arrow in zygotene indicates MEIOK21 foci on an unsynapsed axis, 77.60 ± 8.24% in early/mid zygotene and 26.08 ± 8.98% in late zygotene. The arrowhead indicates MEIOK21 foci on a synapsed axis, 22.40 ± 8.24% in early/mid zygotene and 73.92 ± 8.98% in late zygotene. Mean ± SD, *n* = 20 for each group. The dashed line separates the target cell from the adjacent unrelated cell. Scale bar, 10 μm. (**C**) Quantification of the numbers of MEIOK21 foci in spermatocytes from leptotene to diplotene. Spermatocyte sample sizes, *n* = 20 for each stage. Lep, leptotene; early Zyg, early zygotene; late Zyg, late zygotene; early Pac, early pachytene; late Pac, late pachytene; Dip, diplotene. Error bar, mean ± SD. (**D**) The dynamic localization of MEIOK21 on chromosomes investigated by structured illumination microscope (SIM). (Top panel) MEIOK21 foci first localize on the chromosome axis ('leptotene', arrows). Then, on chromosome regions where two homolog axes are aligned in parallel, MEIOK21 foci were frequently seen as 'pairs' at the opposing sites on the two homologs ('early/mid zygotene', arrows, MEIOK21 foci; blue dotted lines, focus pairs) and some foci are released as 'hanging foci' ('early/mid zygotene', arrowheads). When homologous chromosomes aligned closely, MEIOK21 appears as 'bridges' or 'fusing foci' ('late zygotene', arrowhead) and finally as fused foci ('pachytene', arrowheads) between synapsed axes. (Bottom panel) cartoons illustrate the dynamic localization of MEIOK21 with meiotic progression. Scale bar, 1 μm.](gkaa406fig1){#F1}

Given that *Meiok21* is highly expressed in testes and fetal ovaries, where meiosis occurs, the expression and localization of MEIOK21 in spermatocytes was further examined in detail by chromosome spread combined with immunostaining. Meiotic stages were classified according to standard cytological criteria combined with the morphology of SYCP3, a chromosome axis marker ([@B40]). At the leptotene stage, developing chromosome axes are labelled by short stretches of SYCP3. At the zygotene stage, these discontinuous SYCP3 stretches become linear axes and homologs begin to synapse where the SYCP3 labelled axes are much thicker than unsynapsed regions (Figure [1B](#F1){ref-type="fig"}). When all autosomes completely synapsed, the nucleus enters the pachytene stage. After pachytene, synaptonemal complexes (SCs) gradually disassemble and the nucleus enters the diplotene stage. Finally, SCs disappear from chromosomes except at a few sites where chiasmata hold homologs together ([@B41]). The last stage of meiotic prophase I is diakinesis, when SYCP3 axes break down except at centromeres ([@B41]).

MEIOK21 was first observed on chromosome axes with ∼135 foci at leptotene in spread spermatocytes immunostained with anti-MEIOK21 antibodies (Figure [1B](#F1){ref-type="fig"}). The number of MEIOK21 foci increased to a peak of ∼200 at early zygotene. After that, the number of MEIOK21 foci gradually decreased. At late pachytene, only a small number of MEIOK21 foci were observed and they were undetectable at diplotene when SC began to disassemble (Figures [1B](#F1){ref-type="fig"} and [C](#F1){ref-type="fig"}). However, MEIOK21 foci were found on both synapsed and unsynapsed chromosome regions (Figure [1B](#F1){ref-type="fig"}, arrow vs arrowhead). At early-mid zygotene, ∼77% of MEIOK21 foci were on unsynapsed regions and ∼23% were on synapsed regions. With meiosis progression, MEIOK21 focus number decreased to ∼26% on unsynapsed regions and increased to ∼74% on synapsed regions at late zygotene. Therefore, MEIOK21 dynamically localizes on meiotic chromosomes during prophase of meiosis I.

The dynamic localization pattern of MEIOK21 foci on meiotic chromosomes is quite similar to many well-established recombination factors such as RPA and RAD51/DMC1 recombinase ([@B42]). These observations prompted us to examine the localization of MEIOK21 foci more extensively. Using structured illumination microscopy (SIM), we found that MEIOK21 was located on the chromosome axis as foci at leptotene (Figure [1D](#F1){ref-type="fig"} left, arrows). At zygotene, on chromosome regions where homologous chromosomes were still widely separated, MEIOK21 foci localized on the axis as at leptotene (Figure [1D](#F1){ref-type="fig"} middle left, arrows), while on chromosome regions where two homolog axes were aligned in parallel (800--1000 nm), MEIOK21 foci were frequently seen as 'pairs' at the opposing sites on the two homologs (Figure [1D](#F1){ref-type="fig"} top, middle left, blue dotted lines), and many MEIOK21 foci were seen as 'hanging foci', attached to the sides of axes (Figure [1D](#F1){ref-type="fig"} middle left, arrowheads).

At the more advanced chromosome regions (homolog axes spaced at 300--700 nm), MEIOK21 foci were seen as 'bridge' like structures or 'fusing foci', which is quite common in late zygotene spermatocytes (Figure [1D](#F1){ref-type="fig"} middle right, arrowhead). At pachytene, when all autosomes were synapsed, a majority (∼70%, *n* = 1192 foci) of MEIOK21 foci were located between the synapsed axes, most probably on SC complexes (Figure [1D](#F1){ref-type="fig"} right, arrowheads), although there were still some MEIOK21 foci that remained on the axis or as hanging foci. This progression (Figure [1D](#F1){ref-type="fig"}, lower panels), from on-axis foci to 'hanging foci', then to a 'bridge' like structure and finally to single foci between axes, has been proved to reflect typical dynamics of recombination factors, such as RPA in humans and Msh4 in *Sordaria*, during the meiotic recombination process ([@B31],[@B45],[@B46]). Taken together, the distribution patterns of MEIOK21 coincide with typical features of recombination factors, suggesting its potential roles in meiotic recombination.

MEIOK21 localizes to meiotic recombination sites in a DSB-dependent manner {#SEC3-2}
--------------------------------------------------------------------------

The uniquely dynamic localization of MEIOK21 during meiosis strongly indicates it may function in meiotic recombination. To further investigate this, MEIOK21 was co-immunostained separately with known recombination factors RAD51, DMC1 and RPA protein component (RPA2). We found that MEIOK21 foci colocalized with RPA foci at a high frequency, ∼85-95% of the two factors overlapped with each other from leptotene to early pachytene (Figure [2](#F2){ref-type="fig"}AB). Partial colocalizations were found between MEIOK21 and DMC1 or RAD51. From leptotene to zygotene, ∼40% of MEIOK21 and DMC1 foci overlapped with each other. At early pachytene, ∼20% of MEIOK21 foci overlapped with DMC1 foci, and ∼30% of DMC1 foci overlapped with MEIOK21 foci (Figure [2](#F2){ref-type="fig"}CD). Similar situations were found between MEIOK21 and RAD51. From leptotene to zygotene, ∼60% of MEIOK21 and RAD51 foci overlapped with each other; at early pachytene, ∼20% of MEIOK21 foci overlapped with RAD51 foci, and ∼30% of RAD51 foci overlapped with MEIOK21 foci (Figure [2](#F2){ref-type="fig"}EF).

![MEIOK21 localizes to meiotic recombination sites in a DSB dependent manner. (**A**) MEIOK21 colocalizes with RPA. (**B**) Quantification shows that ∼85-95% of the two factors overlap with each other from leptotene to early pachytene. Error bar, mean ± SD. Sample sizes (from left to right), *n* = 13, 13, 37, 37, 30 and 30, respectively. (**C**) MEIOK21 partially colocalizes with DMC1. (**D**) From leptotene to zygotene, ∼40% of the two factors overlap with each other; in early pachytene, ∼20% of MEIOK21 foci overlap with DMC1 foci, and ∼30% of DMC1 foci overlap with MEIOK21 foci. Error bar, mean ± SD. Sample sizes (from left to right), *n* = 30, 30, 41, 41, 30 and 30, respectively. Arrowheads indicate overlapped foci. (**E**) MEIOK21 partially colocalizes with RAD51. (**F**) From leptotene to zygotene, ∼60% of the two factors overlap with each other; in early pachytene, ∼20% of MEIOK21 foci overlap with RAD51 foci, and ∼30% of RAD51 foci overlap with MEIOK21 foci. Error bar, mean ± SD. Sample sizes (from left to right), *n* = 17, 17, 42, 42, 30 and 30, respectively. Arrowheads indicate overlapped foci. (**G**) MEIOK21 foci are abolished in *Spo11^−/−^* spermatocytes, but more MEIOK21 foci are observed in *Dmc1^−/−^* spermatocytes compared to WT. Note that *Spo11^−/−^* and *Dmc1^−/−^* spermatocytes can only reach the 'zygotene' stage. The dashed line separates the target cell from the adjacent unrelated cell. Scale bar, 10 μm (**A, C, E, G**). (**H**) The quantification of MEIOK21 foci in spermatocytes of WT, *Spo11^−/−^* and *Dmc1^−/−^* mice. Spermatocyte sample sizes, from left to right, n = 19, 22, 17, 20, 22 and 21. Error bar, mean ± SD.](gkaa406fig2){#F2}

The proper localization of recombination factors, including RPA, RAD51 and DMC1, depends on programmed DSBs catalyzed by the SPO11 complex ([@B47]). Thus, we checked whether the localization of MEIOK21 on chromosomes was DSB dependent or not. In WT, there were abundant MEIOK21 foci located on chromosomes in both leptotene and zygotene nuclei (Figure [2G](#F2){ref-type="fig"} left and 2H). However, MEIOK21 foci were rarely observed in *Spo11^−/−^* spermatocytes (Figure [2G](#F2){ref-type="fig"} middle and H). This supports that the chromosome localization of MEIOK21 depends on meiotic DSBs and MEIOK21 may play important roles in DSB repair. In *Dmc1^−/−^* spermatocytes, DSBs are unrepaired and accumulated with extensive resection ([@B48]). The localization of MEIOK21 was further examined in *Dmc1^−/−^* spermatocytes. Consistent with this, the number of MEIOK21 foci was also accumulated to a significantly higher level (Figure [2G](#F2){ref-type="fig"} right versus left; H). Therefore, the localization of MEIOK21 on chromosomes depends on meiotic DSBs and occurs prior to DMC1.

MEIOK21 interacts with HSF2BP {#SEC3-3}
-----------------------------

To clarify the possible function of MEIOK21 during meiotic recombination, we searched for its potential interactors during this process. We focused on RPA and factors that also colocalize with RPA. In mammals, the RPA complex is composed of RPA1, RPA2 and RPA3. Recently, MEIOB, SPATA22 and HSF2BP have been found to colocalize with RPA, and they are all required for meiotic recombination ([@B26],[@B30],[@B49],[@B50]). Thus, these proteins were screened for their possible interactions with MEIOK21 using a yeast two-hybrid (Y2H) assay. Among them, only HSF2BP was detected to interact with MEIOK21 (Figure [3A](#F3){ref-type="fig"}; [Supplementary Figure S2A-C](#sup1){ref-type="supplementary-material"}). To further confirm the interaction between MEIOK21 and HSF2BP, endogenous co-immunoprecipitation (co-IP) assays were performed using WT testis extracts. Consistent with the Y2H result, endogenous HSF2BP could be pulled down by MEIOK21 in co-IP via anti-MEIOK21 antibody. As a negative control, HSF2BP was not detected in co-IP using *Meiok21^−/−^* testis extracts in which MEIOK21 protein is absent (Figure [3B](#F3){ref-type="fig"}). Consistent with the interaction results, ∼75--90% of MEIOK21 foci colocalized with HSF2BP foci, and ∼70--90% of HSF2BP foci colocalized with MEIOK21 foci on meiotic chromosomes from leptotene to pachytene (Figure [3C](#F3){ref-type="fig"} and [Supplementary Figure S2E](#sup1){ref-type="supplementary-material"}). Above results support that MEIOK21 binds to HSF2BP *in vivo*, and functions in meiotic recombination.

![MEIOK21 interacts with recombination factor HSF2BP. (**A**) MEIOK21 interacts with HSF2BP in Y2H screening, with MEIOK21 as prey and HSF2BP as bait. About 10^5^ yeast cells were seeded in each dot. The experiment was repeated three times. (**B**) HSF2BP is pulled-down in *Meiok21^+/+^* testis lysate (+/+) (200 mg) but not *Meiok21^−/−^* testis lysate (−/−) (200 mg) by antibody against MEIOK21.The input amount is ∼5% of the lysate. IgG acts as a negative control. The experiment was repeated three times. Nonspecific bands are labeled with \*. (**C**) MEIOK21 colocalizes with HSF2BP on meiotic chromosomes (see [Supplementary Figure 2E](#sup1){ref-type="supplementary-material"} for quantifications). Scale bar, 10 μm. (**D**) Diagram of MEIOK21 truncations. (**E**) The C terminus of MEIOK21 (a.a. 451--600) is required for interaction with HSF2BP. FLAG-tagged HSF2BP and GFP-tagged MEIOK21 truncations were co-transfected to HEK-293T cells. After 48 hours, cells were lysed, and co-IP experiments were performed using GFP antibody. The input amount is ∼5% of the lysate. The experiment was repeated twice. (**F**) The N terminus of MEIOK21 (a.a. 1--150) is required for its nuclear localization. GFP-tagged MEIOK21 truncations were transfected to HEK-293T cells. After 24 hours, GFP signal was examined under a fluorescence microscope. Scale bar, 5 μm. (**G**) The diagram of HSF2BP truncations. (**H**) The coiled-coil domain of HSF2BP (a.a. 1--92) is required for MEIOK21 binding. GFP-tagged MEIOK21 and FLAG-tagged HSF2BP truncations were co-transfected to HEK-293T cells. After 48 hours, cells were lysed, and co-IP experiments were performed with antibodies against GFP. The input amount is ∼5% of the lysate. The experiment was repeated twice. The non-specific band (\*). (**I**) Diagrams to illustrate interaction domains of MEIOK21 and HSF2BP.](gkaa406fig3){#F3}

Next, we asked which region(s) of MEIOK21 interact(s) with HSF2BP. Since the full- length protein is composed of an unknown structural domain (DUF4671), without any other known functional domains/motifs, several GFP tagged truncations were constructed (Figure [3D](#F3){ref-type="fig"}). We found the GFP-tagged MEIOK21~301-600~ fragments pulled down Flag-tagged HSF2BP as efficiently as full length MEIOK21, while MEIOK21~1--300~ fragments could not pull down HSF2BP (Figure [3E](#F3){ref-type="fig"}, lane 9 versus lane 6). This indicates that the MEIOK21 C-terminal but not the N-terminal fragment is responsible for its interaction with HSF2BP. Further experiments showed that the last 150 amino acids (MEIOK21~451--600~) were sufficient to interact with HSF2BP (Figure [3E](#F3){ref-type="fig"}, lane 12).

Given that MEIOK21 localized in the nucleus (specifically on meiotic chromosomes), but bioinformatic analysis did not identify a nuclear localization sequence, we wondered which region of MEIOK21 mediated its nucleus localization. For this purpose, we first confirmed GFP-tagged full length MEIOK21 protein localized to the nucleus when it was transiently expressed in HEK-293T cells (Figure [3F](#F3){ref-type="fig"}). Then, GFP-tagged MEIOK21 fragments (above) were transfected into HEK-293T cells. The N-terminal fragment containing the first 150 amino acids localized to the nucleus efficiently (Figure [3F](#F3){ref-type="fig"}), which suggests that this fragment contains the nuclear localization signal. However, the fragment lacking the first 150 amino acids, MEIOK21~151--600~, localized to the cytoplasm exclusively (Figure [3F](#F3){ref-type="fig"}). Therefore, MEIOK21 has at least two functional domains, the N-terminal 150 amino acids for nuclear localization and the C-terminal 150 amino acids for interaction with HSF2BP.

HSF2BP has two domains, the N-terminal coiled-coil domain interacting with HSF2 and the C-terminal armadillo domain interacting with BRCA2 and BNC1 ([@B28],[@B51],[@B52]). Our Y2H and co-IP experiments show that the N-terminal domain of HSF2BP but not the C-terminal domain can sufficiently mediate its interaction with MEIOK21 (Figures [3G](#F3){ref-type="fig"}--[I](#F3){ref-type="fig"} and [Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}). However, it is still unknown whether MEIOK21 and HSF2 share the same binding motif at the N-terminus of HSF2BP, and how these two factors interact with and regulate HSF2BP. These questions remain to be further investigated.

MEIOK21 is required for male fertility {#SEC3-4}
--------------------------------------

MEIOK21 specifically localizes on chromosomes in a DSB dependent manner. It colocalizes with RPA and interacts with HSF2BP, which is involved in meiotic recombination. All of these traits strongly suggest that MEIOK21 likely functions directly in meiosis. To test this, *Meiok21* deficient (*Meiok21^−/−^*) mice were generated by deleting exons 3--6 of *Meiok21* using the CRISPR/Cas9 system (Figure [4A](#F4){ref-type="fig"} and [Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}). The knockout efficiency was confirmed by RT-PCR and immunostaining against endogenous MEIOK21 (Figures [4B](#F4){ref-type="fig"} and [Supplementary Figure S3B--F](#sup1){ref-type="supplementary-material"}). *Meiok21^−/−^* mice were viable and appeared to develop normally. Although *Meiok21^−/−^* female mice had no obvious fertility defects, *Meiok21^−/−^* male mice were infertile (Figure [4C](#F4){ref-type="fig"}, [Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). Studies showed that the sizes of testes from 8-week-old *Meiok21^−/−^* male mice were much smaller than those of WT and *Meiok21^+/−^* mice at the same age (Figure [4D](#F4){ref-type="fig"}, E). However, 12-week-old *Meiok21^−/−^* ovaries were still comparable to WT ([Supplementary Figure S4B, C](#sup1){ref-type="supplementary-material"}). Further analysis showed no post-meiotic round spermatids or elongating spermatids in the seminiferous tubules, but there were numerous vacuoles in *Meiok21^−/−^* testes, which were rarely seen in WT testes (Figure [4F](#F4){ref-type="fig"}, upper panel). Moreover, no spermatozoa were found in the cauda epididymis of *Meiok21^−/−^* mice, whereas mature spermatozoa were present in the cauda epididymis of WT (Figure [4F](#F4){ref-type="fig"}, lower panel). TdT-mediated dUTP nick end labeling (TUNEL) staining of *Meiok21^−/−^* testis sections revealed that many spermatocytes underwent apoptosis (Figure [4G](#F4){ref-type="fig"}). These results suggest that in the absence of MEIOK21, a large number of spermatocytes are eliminated before the completion of spermatogenesis, which results in smaller testes as often seen in synapsis- and recombination-defective mutants, such as *Dmc1^−/−^* and *Msh5^−/−^* ([@B44],[@B53],[@B54]). Therefore, MEIOK21 is essential for spermatogenesis and male fertility.

![MEIOK21 is required for male fertility. (**A**) The schematic of *Meiok21* knockout allele. Exons 3--6 were deleted in the mutant. (**B**) *Meiok21* knockout was confirmed by RT-PCR (Materials and Methods). RT-PCR was performed using cDNA obtained from testes as templates. PCR products with proper size were detected from WT but not mutant samples. (**C**) *Meiok21^−/−^* male mice were sterile. *n* = 5 for each genotype. Error bar, mean ± SEM. (**D**, **E**) Both the testis size and testis/body weight ratio of 8-week-old *Meiok21^−/−^* mice are significantly reduced compared to *Meiok21^+/+^*and *Meiok21^+/−^* mice. Error bar, mean ± SEM. *n* = 3 for each genotype. (**F**) No spermatids or mature spermatozoa were observed in testis or epididymis by HE staining in *Meiok21^−/−^* mice. Scale bar, 50 μm. (**G**) A large number of apoptotic spermatocytes (green) were observed in *Meiok21^−/−^* testis by TUNEL staining. Scale bar, 50 μm. (**H**) Quantitative analysis of spermatocytes at different meiotic stages from *Meiok21^+/+^* and *Meiok21^−/−^* mice testes at postnatal day 20. There are more zygotene but less pachytene spermatocytes in *Meiok21^−/−^* testis compared to WT. *n* = 3 for each genotype. Error bar, mean ± SEM.](gkaa406fig4){#F4}

MEIOK21 is important for normal meiosis progression {#SEC3-5}
---------------------------------------------------

Given that *Meiok21^−/−^* spermatocytes are eliminated via apoptosis, we speculate that they may undergo severe defects in meiosis. Spermatogenesis in mice is a continuous process and occurs by waves in seminiferous tubules. Thus, spermatocytes at different stages can be seen in a single seminiferous tubule. The first wave of spermatogenesis is relatively synchronized ([@B55]). The stage(s) in which the defects occur can be easily inferred from meiosis progression. Spermatocytes from leptotene to diplotene can be distinguished based on chromosome immunostaining of SYCP3 and SYCP1, the components of meiotic chromosome axis and SC. Zygotene spermatocytes were dominant in postnatal day 15 (PD15) testis of both WT and *Meiok21^−/−^* mice, and there were slightly more zygotene (∼70% vs ∼65%) and significantly less pachytene (∼7% versus ∼16%) spermatocytes in *Meiok21^−/−^* compared to WT. With meiosis progression, more zygotene cells entered pachytene, thus the frequency of zygotene cells decreased, and concomitantly, the frequency of pachytene cells increased. As expected, at PD17, zygotene spermatocyte frequency decreased to ∼25% and pachytene spermatocyte frequency increased to ∼61% in WT. However, ∼64% of spermatocytes stayed in zygotene and only ∼22% of spermatocytes entered pachytene in *Meiok21^−/−^* mice. At PD20, zygotene spermatocytes further decreased to ∼15% and pachytene spermatocytes increased to ∼72% in WT. But in *Meiok21^−/−^*, zygotene spermatocytes were still at a high level (∼40%) and pachytene spermatocytes only increased to ∼45%, (Figure [4H](#F4){ref-type="fig"}). Therefore, there were always significantly more zygotene spermatocytes and fewer pachytene spermatocytes in *Meiok21^−/−^* mice, compared to WT at the same ages (Figure [4H](#F4){ref-type="fig"}). These observations suggest that in the absence of MEIOK21, meiosis might be arrested or delayed at the zygotene/pachytene transition, and only a subset of spermatocytes that have fewer defects could enter pachytene.

Since no spermatids were found in *Meiok21^−/−^* testis, we focused on seminiferous epithelium to examine the pathological status of spermatogenesis in *Meiok21^−/−^* testes. Mouse spermatogenesis is a highly ordered biological process, and the seminiferous epithelium can be divided into twelve stages (stages I--XII) according to the development of spermatocytes and spermatids, which can be visualized by the periodic acid-Schiff\'s reaction (PAS) ([@B55]). In WT testis, seminiferous tubules from stage I--XII can be observed, and spermatocytes from leptotene to metaphase I, together with round spermatids and elongating spermatids, are organized in corresponding positions ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}; upper panel). In *Meiok21^−/−^* testis, spermatids were never found, and stages of seminiferous epithelium could only be identified based on the types of spermatocytes ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}; lower panel) ([@B55]). Moreover, in *Meiok21^−/−^* tubules, apoptotic spermatocytes were observed as early as stage IV and throughout stages after that. At stage IV, pachytene spermatocytes are dominant in WT tubules, however, many apoptotic pachytene spermatocytes with aberrantly condensed nuclei appeared in *Meiok21^−/−^* tubules ([@B55]) ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}; lower panel, 'aP'). These results suggest that defective *Meiok21^−/−^* pachytene spermatocytes may undergo apoptosis. In addition, apoptotic diplotene (aDi) and apoptotic metaphase I (aMI) spermatocytes were also found in *Meiok21^−/−^* tubules ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}; lower panel, 'aDi' and 'aMI'). Very similar results were observed in both younger and older mice ([Supplementary Figure S5BC](#sup1){ref-type="supplementary-material"}). We speculated that a small subset of *Meiok21^−/−^* spermatocytes with fewer defects could bypass the pachytene checkpoint, but finally undergo apoptosis. Therefore, defective *Meiok21^−/−^* spermatocytes probably are cleared via apoptosis during prophase of meiosis I, which results in male infertility.

*Meiok21^−/−^* spermatocytes show defects in synapsis and crossover recombination {#SEC3-6}
---------------------------------------------------------------------------------

The phenotype of *Meiok21^−/−^* mice is similar to many synapsis or recombination defective mutants ([@B56],[@B57]). Thus, homologous synapsis and meiotic recombination were examined in *Meiok21^−/−^* spermatocytes. By double staining of SYCP3 and SYCP1, two types of synapsis defects were found in *Meiok21^−/−^* spermatocytes that were never seen in WT mice. (i) Synapsis partner switch, i.e. different regions of one chromosome synapses with more than one partner (Figure [5A](#F5){ref-type="fig"}, left panel). In this case, at least one partner is a non-homolog, meaning there is also non-homologous synapsis, which has been reported in several recombination mutants in mice ([@B27],[@B30],[@B44]). (ii) Condensed 'zygotene'. There is a fraction of 'zygotene' nuclei with highly condensed chromosomes as pachytene nuclei, in which there is no or only few short SYCP1 stretches. Thus, in these nuclei homologs are unsynapsed and remained as ∼40 'univalents' but not 20 bivalents as seen in WT pachytene (Figure [5A](#F5){ref-type="fig"}, right panel). This type of synapsis defect is often seen in recombination defective mutants ([@B7],[@B40],[@B44],[@B53]). In total, these two types of abnormal nuclei account for ∼50% of the zygotene spermatocytes in *Meiok21^−/−^* mice (Figure [5B](#F5){ref-type="fig"}). Such abnormalities are not found in *Meiok21^−/−^* oocytes ([Supplementary Figure S4D](#sup1){ref-type="supplementary-material"}). We infer that these nuclei are unable to enter the pachytene stage. This supports the idea that the high level of zygotene nuclei in the mutants is not due to a delay in entering pachytene, but actually due to a fraction of nuclei that permanently arrest in the zygotene stage because of severe synapsis failures. However, we cannot exclude the possibility that these aberrant nuclei are actually at a pachytene-like stage but with pairing/synapsis defects.

![MEIOK21 is required for efficient meiotic recombination. (**A**) Two types of aberrant synapsis are frequently observed in *Meiok21^−/−^* spermatocytes, as seen in other recombination defective mutants. Partner switch (left panel), i.e. one chromosome (arrow) synapses with more than one partner (arrowheads). (**B**) Quantification of the two types of aberrant 'zygotene' nuclei described in (A). For each genotype, 3 mice were examined. The numbers of cells examined in each mouse are 84, 60 and 60 for WT, and 93, 48 and 64 for *Meiok21^−/−^*. (**C**, **D**) The number of crossovers, marked by MLH1 foci (red), is significantly reduced in *Meiok21^−/−^* pachytene spermatocytes compared to WT. *n* = 20 and 23 for WT and *Meiok21^−/−^*, respectively. Chromosomes without even one MLH1 focus (arrows). (**E**, **F**) In *Meiok21^−/−^* spermatocytes, the level of RPA foci is similar to that of WT at zygotene, but there is aberrant retention of RPA on chromosomes at a late time. From left to right, n = 20, 20, 24, 13, 23, 19, 14 and 20, respectively. (**G--L**) The numbers of DMC1, RAD51 and HSF2BP foci are greatly decreased in *Meiok21^−/−^* spermatocytes compared to WT. Early/Mid Zyg, early or middle zygotene; Late Zyg, late zygotene; Pac, pachytene, Late Pac: late pachytene, Dip: diplotene. For each panel from left to right, *n* = 26, 36, 24, 30, 22 and 27 (H), 29, 36, 20, 27, 29 and 31 (J), 20, 21, 22, 21, 21 and 21 (L). Scale bar, 10 μm (A, C, E, G, I, K). Error bar, mean ± SD (D, F, H, J, L) or mean ± SEM (B).](gkaa406fig5){#F5}

As described above, a considerable proportion of *Meiok21^−/−^* spermatocytes can still enter pachytene. In order to characterize whether these pachytene nuclei are normal, meiotic recombination was examined. The final and major purpose of meiotic recombination is the formation of homologous DNA crossovers (COs). COs cause the exchange of homologous DNA and establish the physical connections between homologs required for proper chromosome segregation ([@B12]). Around 90% of mouse COs can be marked by MLH1 foci at pachytene ([@B58]). So, the number and distribution of MLH1 foci were checked by immunostaining in pachytene spermatocytes. Consistent with previous studies, in WT pachytene spermatocytes, ∼22 MLH1 foci were observed per cell and almost every autosome has at least one MLH1 focus, thus autosomes without an MLH1 focus are rare (∼1%). Only ∼17 MLH1 foci were observed per *Meiok21^−/−^* pachytene spermatocyte, with ∼25% autosomes without even one MLH1 focus (Figures [5](#F5){ref-type="fig"}CD, [Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}).

MEIOK21 is required for normal DMC1 and RAD51 recruitment in spermatocytes {#SEC3-7}
--------------------------------------------------------------------------

Meiotic crossover recombination originates from programmed DSBs. Upon DSB formation, γH2AX, the phosphorylated form of the histone variant H2AX, appears and its level is correlated with the level of DSBs ([@B61],[@B62]). In WT spermatocytes, abundant γH2AX signals could be detected in the leptotene stage immediately after DSBs formed ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}, upper two panels). In early pachytene nuclei, these signals decrease on autosomes, and bright signals appear on the XY body ([@B63]). From mid/late pachytene to diplotene, γH2AX signals are barely detectable on autosomes, however, strong signals are still maintained on the XY body. In *Meiok21^−/−^* spermatocytes, γH2AX signals were comparable to WT at leptotene and zygotene, suggesting that a WT level of DSBs are formed. Similar to WT, γH2AX signals also decreased on autosomes in early pachytene nuclei. However, in contrast to WT, a number of γH2AX foci were still maintained on autosomes at mid/late pachytene (45.66 ± 12.41 foci, *n* = 38) and even at diplotene (33.15 ± 14.73 foci, *n* = 47) ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}, lower two panels). This implies that a considerable number of meiotic DSBs remained unrepaired in *Meiok21^−/−^* spermatocytes, though it seems chromosomes synapsed appropriately in these nuclei.

Meiotic DSBs are processed to generate long single strand 3′ overhangs, to which RPA binds ([@B64]). RPA foci appeared from leptotene and the number peaked at zygotene with a similar level in both WT and *Meiok21^−/−^* spermatocytes (179.60 ± 12.55 versus 177.50 ± 7.98) (Figure [5E](#F5){ref-type="fig"}, [F](#F5){ref-type="fig"}). This further confirms that MEIOK21 is not required for DSB formation, and it is also consistent with the fact that localization of MEIOK21 depends on DSBs but not the other way around (above). In WT spermatocytes, the number of RPA foci decreased to a very low level at early/mid pachytene and RPA signals are barely detectable in late pachytene. In *Meiok21^−/−^* spermatocytes, the number of RPA foci also decreased at pachytene, but were still maintained at a relatively high level (73.52 ± 19.11 foci, *n* = 20), and even at diplotene a considerable number of RPA foci could still be observed in many nuclei (13.6 ± 6.51 foci, *n* = 20) (Figure [5](#F5){ref-type="fig"}EF). The aberrant retention of RPA in later prophase I is consistent with the persistence of γH2AX signals at these stages, indicating insufficient DSB repair in *Meiok21^−/−^* spermatocytes.

In meiosis, most DSBs are repaired with homologous templates. Both DMC1 and RAD51 form a nucleoprotein filament on ssDNA of DSBs to help search and invade its homologous partner for successful recombination and synapsis ([@B13],[@B19],[@B65]). At zygotene, abundant DMC1 foci can be observed on chromosomes in WT spermatocytes, and along with DSB repair, the number of DMC1 foci gradually decreases. However, in *Meiok21^−/−^* spermatocytes, only a very low number of DMC1 foci were observed at zygotene (44.14 ± 19.35 in *Meiok21^−/−^* versus 189.81 ± 54.23 in WT; Figure [5](#F5){ref-type="fig"}GH). Similarly, the number of RAD51 foci was also greatly reduced in *Meiok21^−/−^* spermatocytes compared to WT at zygotene (60.06 ± 19.62 versus 159.48 ± 37.33; Figure [5I](#F5){ref-type="fig"}, [J](#F5){ref-type="fig"}). Western blot showed that the expression levels of RAD51 and DMC1 proteins were comparable in *Meiok21^−/−^* mutant and WT ([Supplementary Figure S6C](#sup1){ref-type="supplementary-material"}). These results suggest that MEIOK21 does not affect the DMC1/RAD51 protein expression but is required for DMC1 and RAD51 loading to meiotic DSB ends or their stability on chromosomes. This finding is consistent with two facts described above: (1) MEIOK21 does not affect DSB formation or its level, and (2) DMC1 is not required for MEIOK21 localization to recombination sites.

Greatly reduced DMC1 focus number also suggest greatly reduced levels of inter-homolog recombination interactions in *Meiok21^−/−^* mice (∼20--40% of WT level based on DMC1/RAD51 focus number), which will result in recombination and synapsis defects ([@B13],[@B44]). However, as described above, in *Meiok21^−/−^* pachytene nuclei, the number of MLH1 foci is still at ∼77% of the WT level, which is less affected than inter-homolog recombination interactions (CO precursors) as indicated by DMC1/RAD51 foci (20-40% of WT). This result suggests that CO homeostasis may still exist in *Meiok21^−/−^* spermatocytes. CO homeostasis reflects the fact that when the number of CO precursors is significantly altered, the number of COs can be maintained constantly or only affected less proportionally ([@B66]).

Two other recombination factors, MSH4 and RNF212, which act in the later stages of meiotic recombination, were also examined. The data showed that, without MEIOK21, both MSH4 and RNF212 focus numbers were reduced to ∼70% of WT ([Supplementary Figure S7A--D](#sup1){ref-type="supplementary-material"}), which is comparable to the level of MLH1 foci (∼77% of WT), but much higher than the level of DMC1/RAD51 foci (20--40% of WT). This may explain why a considerable number of MLH1 foci can be formed in *Meiok21^−/−^* spermatocytes, and may also suggest that CO homeostasis (and thus CO/NCO differentiation) occurs at or before MSH4 foci occurrence as previously proposed ([@B15],[@B61],[@B65],[@B68]).

MEIOK21 is essential for sufficient HSF2BP recruitment {#SEC3-8}
------------------------------------------------------

A recent study has reported that HSF2BP interacts with BRCA2 to mediate its localization to recombination sites. As with *Meiok21^−/^*^−^ spermatocytes, *Hsf2bp^−/−^* spermatocytes also have a normal level of DSBs and a low number of DMC1 and RAD51 foci ([@B30]). We further found that MEIOK21 interacted and colocalized with HSF2BP at recombination sites during meiosis. These results suggest that MEIOK21 may regulate DMC1/RAD51 foci through interacting with and modulating HSF2BP. Therefore, the chromosome localization of HSF2BP was examined in WT and *Meiok21^−/−^* spermatocytes. As reported, HSF2BP foci appeared at leptotene, reached the peak at zygotene, then gradually decreased and finally disappeared at late pachytene in WT (Figure [5K](#F5){ref-type="fig"}, L). However, only a low number of HSF2BP foci were detected in *Meiok21^−/−^* spermatocytes compared to WT at corresponding stages (e.g. 63.25 ± 3.229 versus 167.8 ± 6.786 at zygotene; Figure [5K](#F5){ref-type="fig"}, [L](#F5){ref-type="fig"}). Thus, knockout of *Meiok21* leads to a significantly decreased number of HSF2BP foci on meiotic chromosomes.

DISCUSSION {#SEC4}
==========

We identified a new protein, MEIOK21, that is preferentially expressed in testes and fetal ovaries. MEIOK21 specifically localizes on meiotic recombination sites in a DSB dependent manner, and colocalizes with recombination factors RPA and HSF2BP. The dynamic and unique localization patterns of MEIOK21 show that it is a meiotic recombination bridge. The C-terminal domain of MEIOK21 physically interacts with the N-terminal domain of HSF2BP. In *Meiok21^−/−^* spermatocytes, HSF2BP and the recombinases DMC1 and RAD51 cannot efficiently localize to recombination sites, which finally results in severe defects in synapsis and crossover recombination.

MEIOK21 regulates DMC1/RAD51 foci through interaction with HSF2BP {#SEC4-1}
-----------------------------------------------------------------

The formation of MEIOK21 foci on meiotic chromosomes required SPO11 but was independent of DMC1. This observation suggests that MEIOK21 works after DSB formation but before DMC1. Further studies showed that *Meiok21* knockout does not affect RPA recruitment but the number of RAD51/DMC1 foci is significantly reduced. Thus, MEIOK21 probably works after DSB formation and RPA recruitment to regulate RAD51/DMC1 nucleoprotein filament assembly or their stability on chromosomes.

Efficient loading and stabilization of DMC1/RAD51 is required for proper homolog recombination. In *Dmc1* knockout mice, spermatocytes arrest at zygotene with severe defects in meiotic recombination and synapsis ([@B44],[@B54]). The proper function of DMC1 and RAD51 requires many accessory proteins, which regulate the assembly of RAD51/DMC1 on ssDNA and/or the stability of the nucleoprotein filaments ([@B20],[@B22],[@B25],[@B30],[@B69],[@B70]). Compared with core recombinase DMC1/RAD51, the absence of different accessory factors differentially impairs meiotic recombination and synapsis. The absence of some accessory factors, such as HOP2-MND1 and RPA, leads to rarely detectable RAD51/DMC1 or MLH1 foci and severe synapsis defect ([@B29],[@B71]). However, the absence of other accessory factors causes only moderate meiotic defects. For example, in SWS1 or SWSAP1 knockout mice, although significantly decreased, the numbers of RAD51/DMC1 and MLH1 foci are still observed at a considerable level in both spermatocytes and oocytes ([@B14],[@B24]). It is unclear how these accessory proteins work and collaborate to finely regulate meiotic recombination, and why so many factors are required.

MEIOK21 specifically interacts with HSF2BP (Figure [3](#F3){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). In *Meiok21^−/−^* spermatocytes, RAD51/DMC1 foci are detected at ∼1/3 of the WT level, and MLH1 foci are detected at ∼2/3 of WT level (Figure [5](#F5){ref-type="fig"}). These results suggest that MEIOK21 probably regulates RAD51/DMC1 foci formation and/or their stability likely through modulating HSF2BP. This proposal is supported by the fact that the number of HSF2BP foci dropped significantly in *Meiok21^−/−^* spermatocytes (Figure [5K](#F5){ref-type="fig"}, L). However, we cannot exclude the following possibilities: (i) MEIOK21 and HSF2BP regulate each other or cooperate for efficient formation of RAD51/DMC1 foci; (ii) MEIOK21 may directly regulate RAD51/DMC1 foci formation. However, the latter is less likely since no direct interaction is detected between MEIOK21 and RAD51 or DMC1 in our study ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}).

Early studies showed that BRCA2 interacts with DMC1 and RAD51 ([@B72]). A recent study found that HSF2BP can directly interact with RPA and BRCA2, and the localization of GFP tagged BRCA2 is altered when it is electroporated into *Hsf2bp^−/−^* testes ([@B30]). Based on these results, the authors proposed that RPA recruits HSF2BP, which further recruits BRCA2-DMC1/RAD51 to DSB sites by direct physical interactions ([@B30]). However, this electroporation result may not reflect the *in vivo* functional interaction between BRCA2 and HSF2BP. Since BRCA2 is essential for both male and female meiosis ([@B22]), if HSF2BP is required to recruit BRCA2, *Hsf2bp* deficiency should severely affect both male and female meiosis. However, knockout of *Hsf2bp* only mildly affects female meiosis ([@B22],[@B28],[@B30]). Our results show that *Meiok21* knockout significantly decreases HSF2BP focus number but has little or no effect on BRCA2 ([Supplementary Figure S7EF](#sup1){ref-type="supplementary-material"}), and as with *Hsf2bp^−/−^* mutants, *Meiok21^−/−^* mutants severely impair male but not female meiosis. However, we cannot completely exclude the possibility that the residual low level of HSF2BP in *Meiok21* knockout spermatocytes is sufficient to recruit BRCA2 to recombination sites. Thus, further studies are required to elucidate the physical and functional interactions between HSF2BP and BRCA2.

Meiotic homologous recombination bridges {#SEC4-2}
----------------------------------------

Meiotic chromosomes are proposed to be organized as loop-axis structures ([@B32],[@B75]). In this model, each chromatid is assembled in arrays of loops. The base of these loops is the structural 'axis', which is decorated with a set of proteins. Meiotic recombination occurs in the context of and is tightly regulated by this chromosome architecture ([@B15],[@B32],[@B75]). Pre-DSB complexes are loaded onto chromosome loops and then are tethered to the axis where DSBs are formed ([@B32],[@B76]). Based on studies mainly from yeast, it has been proposed that after DSB ends are processed, the first ssDNA end is released from the chromosome axis to search and invade the homologous chromosome to form a D-loop ([@B15],[@B31],[@B32],[@B77]). Thus, this process brings the homologous chromosomes close together. Subsequently, a small subset of these inter-homolog recombination intermediates is selected to become COs, while the rest become NCOs ([@B4],[@B15]). Proteins involved in different recombination steps can be visualized by their different association status with chromosomes ([@B78]).

MEIOK21 first appears as foci on the chromosome axis at leptotene. During early zygotene, MEIOK21 foci are then released but still associated with the axis as 'hanging foci'. Along with meiosis progression, homolog axes align closely and MEIOK21 'bridges' appear to tightly link the two axes. Finally, when homologs synapsed, bigger and brighter single MEIOK21 foci, assumed to be fused foci, can be visualized between the two axes. These dynamic localization patterns are unique to meiotic recombination factors, such as RPA, RAD51, DMC1 and MSH4, in diverse species ([@B31],[@B32],[@B45],[@B46],[@B77],[@B79]). This process has been well documented in *Sordaria* meiosis, where chromosomes in a single nucleus undergo meiosis synchronously and fully aligned homolog axes can be easily observed shortly before synapsis ([@B31],[@B45]). However, in other organisms including mouse, different chromosomes progress asynchronously in the nucleus during meiosis ([@B80]). Moreover, different regions of a pair of homologs can be at significantly different stages, e.g. some regions of chromosome are synapsed, some regions are unsynapsed but homolog axes stay close, and some other regions of homolog axes stay far apart (Figure [1](#F1){ref-type="fig"}BD) ([@B81]). Recombination bridges only can be seen in the right homolog regions at the right time. Recombination bridges are composed of DNA, axis proteins, recombination complex, and mediator complex with intrinsic axis affinity independent of recombination, e.g. ZIP2--ZIP4 complex ([@B31],[@B32]).

The DSB-dependent localization dynamics of MEIOK21 suggests that MEIOK21 is involved in recombination bridges as a member of the recombination complex. In the absence of MEIOK21, the numbers of DMC1 and RAD51 foci are greatly decreased. Therefore, MEIOK21 is required for efficient formation of meiotic recombination bridges. This hypothesis is consistent with the fact that CO recombination as visualized by MLH1 foci occurs but at a significantly decreased level in the absence of MEIOK21 (Figure [5](#F5){ref-type="fig"}CD). The decreased number of inter-homolog recombination cause defects in not only CO recombination but also synapsis as observed, because more homologous recombination interaction sites are required for efficient synapsis than for CO formation ([@B68],[@B82]).

The sexually dimorphic phenotype of *Meiok21* knockout mice {#SEC4-3}
-----------------------------------------------------------

*Meiok21* is highly expressed in both mouse testes and fetal ovaries, but knockout of *Meiok21* showed sexually dimorphic phenotypes: males are infertile, but females have no obvious fertility defects ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). Several other recombination mutants also showed sexual dimorphisms. Known recombination factors regulating DMC1/RAD51 can be classified into two groups. The first group includes HOP2-MND1, BRCA2, MEIOB and the Shu complex SWS1-SWSAP1, whose deletion or mutation leads to severe meiosis defects in both males and females ([@B22],[@B24],[@B26],[@B27],[@B29],[@B83]). The second group includes ATR, HSF2BP, TEX15 and BRCA1. Deletion or mutation of these genes only affect male meiosis and fertility, but have no or little effects on female meiosis or fertility ([@B20],[@B25],[@B28],[@B30],[@B69],[@B70]). MEIOK21 belongs to the second group. The existence of two different types of DMC1/RAD51 regulators suggests different mechanisms regulating meiotic recombination between males and females. One possibility is that the checkpoint is less stringent in females than that in males, thus meiotic errors could be tolerated in oogenesis but not in spermatogenesis ([@B1],[@B84],[@B85]). The consequence of the weak checkpoint in female meiosis is that oogenesis is error prone ([@B86]). Another possibility is that the functions of the second group of genes are male-specific, though some of them are also expressed during female meiosis, or their functions might be redundant in females.
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